EGFR-IN-39

EGFR-IN-39 is a potent and well-tolerated acrylamide-based EGFR inhibitor. It is a valuable research tool for studying EGFR-driven pathologies, such as non-small cell lung cancer (NSCLC), in both cellular and animal models due to its activity against mutant EGFR forms.